Category Specific RSS

asx emd

Testing methylone for PTSD treatment: Emyria’s Centre appointed site for clinical trial

Biotechnology company Emyria (ASX: EMD), which develops treatments for mental health and neurological conditions, has newly inaugurated its treatment facility…

1 year ago

TGA gives green light to Emyria’s psychiatrists for MDMA therapy for PTSD

Mental health treatment provider Emyria (ASX: EMD) has announced that its psychiatry specialist has been granted "Authorised Prescriber" status by…

2 years ago

Treating mental health; TGA approves MDMA and Psilocybin as a medicine

Although it doesn’t apply to me, many of you may remember the early mornings during adolescence when you were throwing…

3 years ago

Does IP ownership of MDMA compounds reduce its potential for healthcare benefits?

If you read my articles often, you would know that I can become quite laudatory when discussing small cap companies…

3 years ago

MDMA usage at University is through the roof as Emyria takes aim at mental health

Harbouring more MDMA than music festival goers, the University of Western Australia (UWA) is leading the way in research around…

4 years ago

Emyria to register cannabinoid-based medicine targeting anxiety and depression

Pharmaceuticals company Emyria (ASX: EMD) is set to commence the regulatory process of registering their cannabinoid-based medicine EMD-003 as a…

5 years ago